Abstract
Objective
Angelica (A.) sinensis is used as a traditional medical herb for the treatment of neurodegeneration, aging, and inflammation in Asia. A. sinensis optimal formula (AOF) is the best combination in A. sinensis that has been screened to rescue the cognitive ability in β-amyloid peptide (Aβ25–35)-treated Alzheimer’s disease (AD) rats. The objective of this study was to investigate the effect of AOF on the learning and memory of AD rats as well as to explore the underlying mechanisms.
Methods
Male Wistar rats were infused with Aβ25–35 for AD model induction or saline (negative control). Five groups of AD rats were fed on AOF at 20, 40, or 80 mL/kg every day, donepezil at 0.9 mg/kg every day (positive control), or an equal volume of water (AD model) intragastrically once a day for 4 weeks, while the negative control rats were fed on water. The Morris water maze test was used to evaluate the cognitive function of the rats. The Aβ accumulation, cholinergic levels, and antioxidative ability were detected by ELISA. Additionally, the candidate mechanism was determined by gene sequencing and quantitative real-time polymerase chain reaction.
Results
The results showed that AOF administration significantly ameliorated Aβ25–35-induced memory impairment. AOF decreased the levels of amyloid-β precursor protein and Aβ in the hippocampus, rescued the cholinergic levels, increased the activity of superoxide dismutase, and decreased the malondialdehyde level. In addition, AOF inhibited the expression of IL1b, Mpo, and Prkcg in the hippocampus.
Conclusion
These experimental findings illustrate that AOF prevents the decrease in cognitive function and Aβ deposits in Aβ25–35-treated rats via modulating neuroinflammation and oxidative stress, thus highlighting a potential therapeutic avenue to promote the co-administration of formulas that act on different nodes to maximize beneficial effects and minimize negative side effects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Roy DS, Arons A, Mitchell TI, et al. Memory retrieval by activating engram cells in mouse models of early Alzheimer’s disease. Nature, 2016,531(7595):508–512
Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med, 2010,362:329–344
Yang WN, Han H, Hu XD, et al. The effects of perindopril on cognitive impairment induced by d-galactose and aluminum trichloride via inhibition of acetylcholinesterase activity and oxidative stress. Pharmacol Biochem Behav, 2013,114:31–36
Ong WY, Wu YJ, Farooqui T, et al. Qi Fu Yin-a Ming Dynasty Prescription for the Treatment of Dementia. Mol Neurobiol, 2018,55(9):7389–7400
Lu J, Guo PF, Liu XQ, et al. Herbal Formula Fo Shou San attenuates Alzheimer’s disease-related pathologies via the gut-liver-brain axis in APP/PS1 mouse model of Alzheimer’s disease. Evid Based Complement Alternat Med, 2019,2019:8302950
Cai H, Luo Y, Yan X, et al. The mechanisms of bushenyizhi formula as a therapeutic agent against Alzheimer’s disease. Sci Rep, 2018,8(1):3104
Sun H, Hu Y, Zhang JM, et al. Effects of one Chinese herbs on improving cognitive function and memory of Alzheimer’s disease mouse models. Zhongguo Zhong Yao Za Zhi (Chinese), 2003,28(8):751–754
Fang L, Xiao XF, Liu CX, et al. Recent advance in studies on Angelica sinensis. Chin Herb Med (Chinese), 2012,4:12–25
Wei WL, Zeng R, Gu CM, et al. Angelica sisensis in China- A review of botanical profile, ethanopharmacology, phytochemistry and chemical ananylsis. J Ethnopharmacol, 2016,190:116–141
Wang HP, Wu HY, Li HL, et al. Effects of Angelica Polysaccharide on Learning and Memory Abilities and Aβ Metabolism in Model Rats with Alzheimer Disease. Chin J Informat Tradition Chin Med (Chinese), 2018,25(4):51–55
Wang HP, Wu HY, Li HL, et al. Compatibility optimization of composing prescription on active components of Danggui (Radix Angelicae senensis) for prevention and cure of Alzheimer’s disease (AD). J Gansu Univ Chin Med (Chinese), 2019,36(3):12–19
Zhang Y, Xiu MM, Zhang QH, et al. Novokinin inhibits gastric acid secretion and protects against alcohol-induced gastric injury in rats. Alcohol, 2016,56:1–8
Gong G, Qi B, Liang YT, et al. Danggui Buxue Tang, an ancient Chinese herbal decoction, protects β-amyloid induced cell death in cultured cortical neurons. BMC Complement Altern Med, 2019,19(1):9
Kanski J, Aksenova M, Stoyanova A, et al. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J Nutr Biochem, 2002,13(5):273–281
Chen D, Tang J, Khatibi NH, et al. Treatment with Z-ligustilide, a component of Angelica sinensis, reduces brain injury after a subarachnoid hemorrhage in rats. J Pharmacol Exp Ther, 2011,337(3):663–672
Vassar R, Bennett BD, Babu-Khan S. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 1999,286:735–741
Osborn LM, Kamphuis W, Wadman WJ, et al. Astrogliosis: An integral player in the pathogenesis of Alzheimer’s disease. Prog Neurobiol, 2016,144:121–141
Canter RG, Penney J. The road to restoring neural circuits for the treatment of Alzheimer’s disease. Nature, 2016,539:187–196
Lu C, Dong L, Lv J, et al. 20(S)-protopanaxadiol (PPD) alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of Egr-1, c-Fos and c-Jun in mice. Chem Biol Interact, 2018,279:64–72
Ballard CG, Greig NH, Guillozet-Bongaarts AL, et al. Cholinesterases: roles in the brain during health and disease. Curr Alzheimer Res, 2005,2(3):307–318
Yang B, Sun X, Lashuel H, et al. Reactive oxidative species enhance amyloid toxicity in APP/PS1 mouse neurons. Neurosci Bull, 2012,28(3):233–239
Jiang TF, Sun Q, Chen SD. Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease. Prog Neurobiol, 2016,147:1–19
Manso H, Krug T, Sobral J, et al. Variants in the inflammatory IL6 and MPO genes modulate stroke susceptibility through main effects and gene-gene interactions. J Cereb Blood Flow Metab, 2011,31(8): 1751–1759
Parajuli B, Sonobe Y, Horiuchi H, et al. Oligomeric amyloid B induces IL-1b processing via production of ROS: implication in Alzheimer’s disease. Cell Death Dis, 2013,4:e975
Xie LS, Lai Y, Lei F, et al. Exploring the association between interleukin-1β and its interacting proteins in Alzheimer’s disease. Mol Med Rep, 2015,11(5):3219–3228
Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer’s disease mice. J Neurosci, 2008,28(33):8354–8360
Reynolds WF, Rhees J, Maciejewski D, et al. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer’s disease. Exp Neurol, 1999,155(1):31–41
Green PS, Mendez AJ, Jacob JS, et al. Neuronal expression of myeloperoxidase is increased in Alzheimer’s disease. J Neurochem, 2004,90(3):724–733
Maki RA, Tyurin VA, Lyon RC, et al. Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease. J Biol Chem, 2009,284(5): 3158–3169
Hulsdunker J, Zeiser R. In Vivo Myeloperoxidase Imaging and Flow Cytometry Analysis of Intestinal Myeloid Cells. Methods Mol Biol, 2016,1422:161–167
Wong MMK, Hoekstra SD, Vowles J, et al. Neurodegeneration in SCA14 is associated with increased PKCr kinase activity, mislocalization and aggration. Acta Neuropathol Commun, 2018,6(1):99
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that there is no conflict of interest with any financial organization, corporation, or individual that can inappropriately influence this work.
Additional information
This project was supported by the National Natural Science Foundation of China (No. 81960828).
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, Hp., Wu, Hy., Ma, Cl. et al. Optimal Formula of Angelica sinensis Ameliorates Memory Deficits in β-amyloid Protein-induced Alzheimer’s Disease Rat Model. CURR MED SCI 42, 39–47 (2022). https://doi.org/10.1007/s11596-022-2528-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-022-2528-1